Bactiguard Holding ABCHIX:BACTBS 52 PB Ratio is 14.46 as of Jun. 26, 2026, which is 203% above its 10-year median of 4.78. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr264.39. The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Bactiguard Holding AB ranks better than 53.93% on this metric.
Bactiguard Holding AB stock PB Ratio (=1.85) is close to 5-year low of 1.67.
The historical rank and industry rank for Bactiguard Holding AB's PB Ratio or its related term are showing as below:
CHIX:BACTBs'
s PB Ratio Range Over the Past 10 Years
Min: 1.11 Med: 4.78 Max: 18.52
Current: 1.85
During the past 13 years, Bactiguard Holding AB's highest PB Ratio was 18.52. The lowest was 1.11. And the median was 4.78.
CHIX:BACTBs's PB Ratio is ranked better than 53.93% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs CHIX:BACTBs: 1.85
During the past 12 months, Bactiguard Holding AB's average Book Value Per Share Growth Rate was -1.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -14.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -8.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -2.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bactiguard Holding AB was 11.50% per year. The lowest was -91.00% per year. And the median was -14.00% per year.
Back to Basics: PB Ratio
Bactiguard Holding AB (CHIX:BACTBs) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bactiguard Holding AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bactiguard Holding AB (CHIX:BACTBS) has a PB Ratio of 14.46 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bactiguard Holding AB and its competitors. This is 203% above median its historical median of 4.78. Over the past decade, Bactiguard Holding AB's PB Ratio has ranged from 1.11 to 18.52. According to the industry distribution chart, Bactiguard Holding AB ranks #363 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 46.1%.
Is Bactiguard Holding AB's PB Ratio too high?
Bactiguard Holding AB's current PB Ratio of 14.46 is 203% above median its 10-year median of 4.78. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 18.52. The Medical Devices & Instruments industry median PB Ratio is 2.02. Bactiguard Holding AB's value of 14.46 is 615.8% above this industry median. Based on the distribution chart, Bactiguard Holding AB ranks #363 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #363 out of 788 companies for PB Ratio. This puts Bactiguard Holding AB in the upper half of its industry. The industry median PB Ratio is 2.02. Bactiguard Holding AB's value of 14.46 is 615.8% above this benchmark. Historically, Bactiguard Holding AB's own PB Ratio has ranged from 1.11 to 18.52 over the past decade. While the company's 10-year median is 4.78 vs. the industry median of 2.02, Bactiguard Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bactiguard Holding AB's current PB Ratio of 14.46 is 615.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current PB Ratio is 14.46, which is 203% above median its own 10-year median of 4.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current PB Ratio of 14.46. The stock's GF Value™ is kr264.39, compared to a current price of kr128.60 — trading 51.4% below its estimated fair value. The current PB Ratio is 14.46, which is 203% above median its 10-year median of 4.78 and 615.8% above the Medical Devices & Instruments industry median of 2.02. Bactiguard Holding AB's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current PB Ratio is 14.46 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 51.4% below its estimated GF Value™ of kr264.39.
Key valuation signals for CHIX:BACTBS:
PB Ratio: 14.46 (203% above median its 10-year median of 4.78)
GF Value™: kr264.39 vs. price of kr128.60 (51.4% below fair value)
Industry Position: 615.8% above the Medical Devices & Instruments median (#363 of 788)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score
Get the complete analysis for CHIX:BACTBS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
